Network Meta Analysis of Mean Survival
By: Anastasios Apsemidis, Dimitris Mavridis, Nikolaos Demiris
Decisions based upon pairwise comparisons of multiple treatments are naturally performed in terms of the mean survival of the selected study arms or functions thereof. However, synthesis of treatment comparisons is usually performed on surrogates of the mean survival, such as hazard ratios or restricted mean survival times. Thus, network meta-analysis techniques may suffer from the limitations of these approaches, such as incorrect proportional hazards assumption or short-term follow-up periods. We propose a Bayesian framework for the network meta-analysis of the main outcome informing the decision, the mean survival of a treatment. Its derivation involves extrapolation of the observed survival curves. We use methods for stable extrapolation that integrate long term evidence based upon mortality projections. Extrapolations are performed using flexible poly-hazard parametric models and M-spline-based methods. We assess the computational and statistical efficiency of different techniques using a simulation study and apply the developed methods to two real data sets. The proposed method is formulated within a decision theoretic framework for cost-effectiveness analyses, where the `best' treatment is to be selected and incorporating the associated cost information is straightforward.
Similar Papers
Network Meta-Analysis of survival outcomes with non-proportional hazards using flexible M-splines
Methodology
Helps doctors compare new cancer drugs better.
Meta-analysis of median survival times with inverse-variance weighting
Methodology
Combines survival data from cancer studies.
Bayesian random-effects meta-analysis of aggregate data on clinical events
Methodology
Helps doctors find rare bad reactions to medicine.